amgen glp 1 drug What to know about MariTide, Amgen's experimental GLP-1 Development Progress and Prospects of

Current Opinion in Pediatrics , 36(5), 542-546

Though self-injection might initially feel intimidating, it is a straightforward and manageable process with practice and preparation

The data suggest that GLP-1s do not increase the risk of cancer and may even reduce the risk of several types of cancer, particularly in people with obesity or Type 2 diabetes

GLP-1 Safety: Known Risks and Rare Complications While GLP-1 medications are clinically proven to be safe, they carry specific risks that require professional oversight

Ethics statement The studies involving humans were approved by the Institutional Review Board at the University of Texas Health Science Center at San Antonio

Obesity and cancer: A current overview of epidemiology, pathogenesis, outcomes, and management